Hong Kong Stocks Midday Review | Hang Seng Index Rises 0.29% in Morning Session, CRO Concept Stocks Advance

Stock News
11小时前

The Hang Seng Index gained 0.29%, up 75 points to 26,463 points, while the Hang Seng Tech Index rose 1.11%. Hong Kong stocks recorded HK$162 billion in turnover during the morning session.

CRO concept stocks advanced in the morning session, with Pharmaron (03759) surging over 8% as clinical trial approval processes for innovative drugs continue to accelerate. Pharmaron (03759) gained 7.95%; Joinn Laboratories (06127) rose 7%; WuXi Biologics (02269) climbed 5.5%; and Asymchem Laboratories (06821) increased 4.2%.

TRANSTHERA-B (02617) surged over 33% again, as the company was included in the Stock Connect eligible list, effective from September 8th.

The lithium battery sector led gains, with Morgan Stanley issuing a positive research report on CATL, as institutions noted market attention on lithium battery demand expectations for next year. China Innovation Aviation Technology (03931) rose 4%; CATL (03750) gained 7%; and Ganfeng Lithium (01772) increased 4%.

YUNFENG FIN (00376) surged over 19% again, doubling its share price within the month, after Yunfeng Securities recently received approval to provide virtual asset trading services.

Repulse Energy (00666) rose nearly 2% again, as several leading battery cell manufacturers continue operating at full capacity, with the company's energy storage battery shipments showing strong growth.

Shuyi Burning Fairy Grass (02589) gained over 8% after being recently included in the Stock Connect list, with steady growth in store count during the first half of the year.

BRAINAURORA-B (06681) once surged 83% to hit a new high, closing the morning session up 36%, with cumulative gains of over 130% since joining Stock Connect. Starting September 8th, BRAINAURORA-B was officially included in the Stock Connect eligible list. The company is reportedly China's first to develop medical-grade digital therapeutic products for cognitive disorders.

Biocytogen-B (02315) rose over 11% after signing an antibody option evaluation agreement with Merck to advance antibody-drug conjugate lipid delivery solutions.

Property stocks declined collectively, with Shimao Group (00813) falling nearly 5% and China Liangs Holdings (02772) dropping over 3%.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10